Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.
about
Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhibition of ataxia telangiec ...... g cancer (NSCLC) radiotherapy.
@en
type
label
Inhibition of ataxia telangiec ...... g cancer (NSCLC) radiotherapy.
@en
prefLabel
Inhibition of ataxia telangiec ...... g cancer (NSCLC) radiotherapy.
@en
P2093
P50
P1476
Inhibition of ataxia telangiec ...... ng cancer (NSCLC) radiotherapy
@en
P2093
Caroline B M Coffey
Conor K McGarry
Donna M Small
Mihaela Ghita
Victoria Dunne
P304
P356
10.1016/J.RADONC.2017.06.025
P577
2017-07-08T00:00:00Z